Reports of high faecal excretion of bile acids and bile derivatives by patients with colorectal cancer and those with cholecystectomy' 2 have intensified research into the relation between gall stones and colorectal cancer. Several studies of gall stone patients have been reported3-12; most showed a positive association with cancer of the colon, with relative risks of 1-2-2.4. In the studies that showed an effect and provided data on risk by anatomical subsite, the risk was generally greater for cancer of the proximal colon than for other parts of the colon and rectum.8-12
1.2), which remained unchanged when analysed by sex, anatomical subsite, and duration of follow up. Multivariate analysis with adjustment for cholecystectomy and clinically defined obesity did not change these estimates to any significant extent. Excess risks were found for cancers of the pancreas and the small intestine. A non-significant increased risk for breast cancer was seen in women five years after initial discharge for gall stones. Conclusion-A borderline significant association was seen between gall stones and cancer of the colon, and for cancer of pancreas and small intestine as well as for breast cancer in women. (Gut 1996; 39: 439-443) Keywords: gall stones, cholecystectomy, obesity, colorectal cancer.
Reports of high faecal excretion of bile acids and bile derivatives by patients with colorectal cancer and those with cholecystectomy' 2 have intensified research into the relation between gall stones and colorectal cancer. Several studies of gall stone patients have been reported3-12; most showed a positive association with cancer of the colon, with relative risks of 1-2-2.4. In the studies that showed an effect and provided data on risk by anatomical subsite, the risk was generally greater for cancer of the proximal colon than for other parts of the colon and rectum. [8] [9] [10] [11] [12] Although the relation between cholecystectomy and colorectal cancer has been considered in many studies, the results are equivocal"; most of the case-control studies showed a positive relation, but only the two largest cohort studies showed significantly increased risks, which were restricted to women and to the proximal part of the colon. '4 15 These results suggest that gall stones, and possibly cholecystectomy, which are done mainly as a result of gall stones increase the risk for colon cancer, particularly among women and in the proximal part of the colon. One hypothesis is that post-cholecystectomy changes in the composition and secretion of bile salts affect enterohepatic circulation and exposure of the colon to bile acids,'6 '`which may promote the development of colon cancer.'8 On the other hand, abnormal bile acid and cholesterol metabolism that predisposes to gall stones also may increase the risk of colon cancer.'9 The relation may also be influenced by shared determinants of gall stones and colon cancer such as oestrogens and obesity.20 21 This study has the advantage in that it reports colon cancer as well as all other types of cancer among more than 40 000 gall stone patients both with and without cholecystectomy in a large population based design. The analyses included information on a diagnosis of obesity. (Table I ). Among them, 72% had cholecystectomy, and 95% of which were performed within a year of the index gall stone diagnosis.
Patients were followed up for cancer occurrence from one year after discharge for gall stones until the date of death or the end of 1992, whichever came first. The observed numbers of cancers were compared with those expected on the basis of national incidence rates, which are divided into groups according to sex, age, and calendar time in five year intervals. Multiplication of the person years under observation by the incidence rate yields the number of cancers that would be expected if patients with gall stones experienced the same risk as that prevailing in the general population of Denmark. Tests of significance and 95% confidence intervals (CI) for the relative riskthat is, the ratio of observed to expected cancers, were computed on the assumption that the observed number of cancer cases in a specific category follows a Poisson distribution, using Byar's approximation.25 Risks were estimated separately for patients with and without a cholecystectomy, as well as for the entire cohort combined. In addition, the effect of cholecystectomy, obesity, sex, age at diagnosis of gall stones and latency since first discharge with a gall stone diagnosis were adjusted for in multiplicative Poisson regression models that incorporated the national rates as the standard,26 using the Epicure statistical package.27 As the risks were not affected substantially by adjustment for these factors, only results adjusted for age, sex, and calendar years will be presented in the Tables.
Results
The 42098 gall stone patients included in the study accrued 312784 person years of follow up, with an average of 7.4 years each (range, 1-16 years). The median age at the entry in the cohort was 63 years for men and 57 years for women. The male to female ratio was 0.4. A diagnosis of obesity was noted in 2190 (5.2%) patients (Table I) .
Overall, 3940 cancers were observed compared with 3670 expected, yielding a small but significantly increased relative risk of 1.07 (Table II) , 1.07 in men and 1P08 in women.
The increase was due mainly to slight but statistically significant increases in the risk for non-melanoma skin cancer (RR, 1.04), cancers of the breast (1-05), colon (1.09; 1.17 in men and 1.06 in women), kidney (1P21), buccal cavity and pharynx (1P25), pancreas (1.33), and oesophagus (1.34), and of leukaemia (1 35). Greater increases in the risk were found for cancer ofthe liver (1 -70) and small intestine (2.60; 2.18 in men and 2.84 in women). However, with duration of follow up risks remained significantly increased only for cancers of the breast, pancreas, leukemia, and small intestine (Table III) . No excess was observed for cancer of the rectum in either of the sexes (RR in both sexes combined, 0 96). (Table IV) . Multivariate analysis, with adjustment for cholecystectomy and clinically defined obesity, did not change these estimates to any significant extent (data not shown). On the basis of more than 500 observed cases of breast cancer among gall stone patients, we found that the overall risk was increased by some 5%. This modest but significant increase ranged from below unity at the start of the follow up (1-4 years) to some 17% above unity in the last period of follow up (5-16 years) (Table III) . A closer follow up of patients showed that excess risk for breast cancer appeared five years after discharge for gall stones and remained non-significantly increased in the following years (Table V) . The mutivariate analysis did not reveal separate effects of cholecystectomy and obesity and no significant trend was observed in the risk of breast cancer among women (data not shown). Table V also shows that the slightly increased risk for colon cancer remained almost unchanged in all follow up intervals.
Discussion
We report a modest, but significantly increased relative risk for cancers at all sites in a large nationwide cohort of 42 098 gall stone patients J7ohansen, Chow, Jorgensen, Mellemkjaer, Engholm, Olsen with 1-16 years of follow up. In previous studies, the occurrence of gall stones has been associated with an increased risk for colon cancer (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . In our study the modest 9% increased risk for colon cancer remained unchanged when analysed by sex, latency and anatomical subsites of the colon. Although a causal relation between gall stones and colon cancer cannot be excluded on the basis of these results the weakness of the association more likely points to the effects of shared risk factors for these two diseases, such as metabolic factors, dietary factors or unknown factors. The absence of a convincing link between the occurrence of gall stones and colon cancer in our study might be explained by the high number of gall stone patients in the population who remains undiagnosed.30 All We observed a persistent increase in the risks for cancer of the pancreas and small intestine. To the best of our knowledge, neither cancer site has been associated with the occurrence of gall stones in earlier studies,'0 29 and a chance finding cannot be excluded.
Our finding of an increasing risk of breast cancer by duration of follow up is in line with one Swedish case control study of women with breast cancer, which showed a significantly positive association with gall stones.5 Another large cohort study with a maximum of 14 years of follow up showed no association on the basis of 202 observed breast cancers. 30 Furthermore, no association between cholecystectomy and breast cancer was seen in the two case control studies of small sample size.3l3 However, a smaller cohort study with a maximal follow up of 30 years showed a significantly increased risk on the basis of 27 cases.29 In our study the risk estimates for the first part of the follow up period may have been influenced by the exclusion of early, asymptomatic breast cancers during clinical preparation for gall stones.
The non-significant increased risk of breast cancer that appears five years after a diagnosis of gall stones in our study is probably not explained by heightened medical surveillance. Our results suggest that metabolic, hormonal or other determinants of gall stones may be risk factors for breast cancer.
In conclusion, we observed a borderline significant association between gall stones and cancer of the colon, which remained unchanged with duration of follow up. In addition the risk was not clearly confined to the proximal part of colon. We found that gall stone patients had an excess risk for gastrointestinal cancers, including the pancreas and small intestine and a non-significant risk of breast cancer was seen in women at least five years after a gall stone diagnosis. Cholecystectomy did not change these results.
